Sangamo Therapeutics, Inc. (LON: 0R1D)

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $49.41M USD in the quarter ending September 30, 2024, with 425.77% growth. This brings the company's revenue in the last twelve months to $52.29M, down -74.04% year-over-year. In the year 2023, Sangamo Therapeutics had annual revenue of $176.23M with 58.34% growth.

• Revenue (ttm): $52.29M
• Revenue Growth: -74.04%
• P/S Ratio: n/a
• Revenue / Employee: $129.11K
• Employees: 405
• Market Cap: 206.47M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%
Dec 31, 2019	102.43M	17.98M	21.29%